OptimizeRx Corp

OptimizeRx Corp. is digital health company, engaging in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Rochester, MI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

OptimizeRx Corp exceeds revenue expectations, eyes growth through strategic deals

OptimizeRx Corp's strong revenue performance and focus on Real-World Data deals position them for growth despite challenges in revenue retention and operating expenses.
The company's strategic initiatives, including share repurchase, capacity utilization, and omnichannel expansion, showcase resilience and potential for market capture.
By leveraging RWD-AI models, focusing on strategic partnerships, and expanding service offerings, OptimizeRx aims to achieve financial and operational goals in 2023.

OptimizeRx Corp reports solid Q1 performance and eyes growth opportunities

OptimizeRx Corp (OPRX) reported solid Q1 performance, meeting revenue expectations and maintaining full-year outlook with a 10% YoY increase expected. The company showcased strengths in strategic partnerships, RWD-AI solutions, and effective use cases for RWE products.
Despite challenges in operating expenses and net revenue retention rate decline, the company is focused on innovation and growth opportunities through M&A, technology investments, and service expansion. By addressing challenges and leveraging opportunities, OptimizeRx Corp aims for sustainable growth and market differentiation.
With a strong emphasis on product execution, customer ROI, and shareholder value enhancement through a share repurchase program, OptimizeRx Corp is positioning itself for continued success in the healthcare technology sector. The company's strategic initiatives and focus on revenue diversification signal a promising outlook for future growth.

OptimizeRx Corp reports Q2 results, focuses on AI growth

OptimizeRx Corp navigated challenges in Q2 2023 with a focus on financial stability, operational efficiency, and strategic growth initiatives.
Despite disappointment with results, the company remains optimistic about the future of digital marketing in healthcare and the potential of AI-driven solutions.
With a strong balance sheet, emphasis on core business areas, and plans for cost management, OptimizeRx is positioned to capitalize on growth opportunities.
The company's commitment to renewals, upsells, and AI-driven engagement underscores a proactive approach to revenue retention and customer satisfaction.

OptimizeRx Corp (OPRX) beats Q3 expectations, eyes robust 2024 growth

OptimizeRx's Q3 performance exceeded expectations, showcasing strong financials and strategic acquisitions driving growth. While competitors face challenges, OptimizeRx is poised for further expansion and revenue increase in 2024 through enhanced platforms and market opportunities.

OptimizeRx Corp exceeds revenue expectations, eyes $100M target in 2024

OptimizeRx Corp delivered exceptional Q4 2023 results, driven by organic messaging strength and the Medicx Health acquisition.
The company's focus on digital solutions and strategic partnerships positions it well for future growth and capturing pharma spend.
While facing macroeconomic challenges, OptimizeRx's progress in Medicx Health integration and DAAP platform growth present promising opportunities.

OptimizeRx Corp reports robust Q1 performance, eyes sustained growth

OptimizeRx Corp's Q1 2024 performance reflects strong revenue growth, improved gross margin, and positive operating cash flow, underpinned by a focus on DAAP and stakeholder engagement.
While facing challenges in profitability and seasonality impact, the company remains optimistic about scaling DAAP, accelerating revenue growth, and enhancing performance in the second half of the year.
With opportunities to drive revenue through cross-selling, expanding infrastructure, and leveraging AI models, OptimizeRx is poised for sustainable growth and market leadership.

OptimizeRx Corp reports 30% revenue growth in Q3 2024

OptimizeRx Corp (OPRX) showcased strong revenue growth in Q3 2024, driven by HCP business performance.
While facing challenges in the DTC segment, the company is focused on enhancing customer relationships and operational efficiency.
With a positive outlook on growth and strategic initiatives in place, OptimizeRx Corp (OPRX) is poised for future success.
The company's emphasis on technological innovation and customer-centric approaches positions it well for industry advancements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.

Campano Brings More than 15 Years of Experience Leading Digital Channel Partnerships and Innovation Campano Brings More than 15 Years of Experience Leading Digital Channel Partnerships and Innovation

Point-of-Care Industry Expert, Angelo Campano, Joins OptimizeRx Executive Leadership as Senior Vice President and Principal of Agency Channels

OptimizeRx Corporation (OPRX) CEO William Febbo on Q3 2020 Results - Earnings Call Transcript

Shares of OptimizeRx (NASDAQ:OPRX) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 240.00% over the past year to $0.07, which beat the estimate of $0.04.

OptimizeRx: Q3 Earnings Insights

ROCHESTER, Mich., Nov. 09, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, reported results for the three and nine months ended September 30, 2020. Quarterly and nine months comparisons are to the same year-ago period.

OptimizeRx Third Quarter 2020 Revenue Up 110% to Record $10.5 Million, Driving Non-GAAP Net Income of $1.1 million or $0.07 Per Share

ROCHESTER, Mich., Oct. 26, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a conference call on Monday, November 9, 2020 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2020. OptimizeRx management will host the call, followed by a question and answer period.

OptimizeRx Sets Third Quarter 2020 Conference Call for Monday, November 9, 2020 at 4:30 p.m. ET

ROCHESTER, Mich., Oct. 20, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to participate in two investor conferences being held in November.

OptimizeRx to Participate at Investor Conferences in November

3Q20 revenue growth of ~100% is an indicator that the company is converting on its pipeline.

OptimizeRx Is Gaining Traction

ROCHESTER, Mich., Oct. 13, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported preliminary unaudited revenue for its third quarter ended September 30, 2020.

OptimizeRx Expects Record Revenue Exceeding $10.0 Million in Q3 2020, up 100%

NEW YORK, Oct. 5, 2020 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of OptimizeRx Corporation (NASDAQ: OPRX). If you...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating OptimizeRx Corporation for Potential Breaches of Fiduciary Duty By Its Board of Directors

OptimizeRx (OPRX) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

OptimizeRx (OPRX) Looks Good: Stock Adds 9.5% in Session

Presented in Collaboration with the Digital Health Coalition and Diligent Health Solutions Presented in Collaboration with the Digital Health Coalition and Diligent Health Solutions

OptimizeRx Continues Webinar Series, Introducing Innovative Ideas for Transforming New Medication Launches

Patients Gain Direct Access to Financial Assistance Relevant to Their Health Journey Prior to Their Medical Appointment

OptimizeRx Expands Direct-to-Patient Reach, Partnering with Epion Health to Provide Adherence and Affordability Support at Point-of-Care

ROCHESTER, Mich., Sept.  09, 2020  (GLOBE NEWSWIRE) --  OptimizeRx Corp.  (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, providers and patients, has been invited to participate in two investor conferences being held in September.

OptimizeRx to Participate at Investor Conferences in September

As of late, it has definitely been a great time to be an investor in OptimizeRx.

OptimizeRx's Shares March Higher, Can It Continue?

Healthcare Consumers Will Gain Access to Financial Assistance and Treatment Support Programs from OptimizeRx at Point-of-Dispense Healthcare Consumers Will Gain Access to Financial Assistance and Treatment Support Programs from OptimizeRx at Point-of-Dispense

OptimizeRx Enters Retail Pharmacies, Supporting Adherence by Bringing Prescription Savings Directly to Patients via Higi Smart Health Stations

OptimizeRx Corporation (OPRX) CEO William Febbo on Q2 2020 Results - Earnings Call Transcript

ROCHESTER, Mich., Aug.  05, 2020  (GLOBE NEWSWIRE) --  OptimizeRx Corp.  (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported results for the second quarter and six months ended June 30, 2020. Quarterly and first half comparisons are to the same year-ago period.

OptimizeRx Reports Second Quarter 2020 Revenue Up 25% to a Record $8.8 Million; First Half Revenue up 34% to Record $16.4 Million, with Accelerated Growth Expected in Second Half

Change Healthcare Users Gain Access to Prescription Savings and Critical Treatment Information Directly at the Point-of-Care Change Healthcare Users Gain Access to Prescription Savings and Critical Treatment Information Directly at the Point-of-Care

OptimizeRx Joins with Change Healthcare to Expand Nationwide Platform Reach

ROCHESTER, Mich., July  23, 2020  (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, will hold a conference call on Wednesday, August 5, 2020 at 4:30 p.m. Eastern time to discuss results for the second quarter ended June 30, 2020. The financial results will be issued in a press release prior to the call.

OptimizeRx Sets Second Quarter 2020 Conference Call for Wednesday, August 5, 2020 at 4:30 p.m. ET

ROCHESTER, Mich., July  21, 2020  (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has appointed Greg Wasson, former president and CEO of Walgreen Boots Alliance, to its board of directors.

OptimizeRx Appoints Greg Wasson, Former President and CEO of Walgreens Boots Alliance, to Its Board of Directors

ROCHESTER, Mich., July  07, 2020  (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, has secured two new SaaS-based enterprise-level engagements that provide the full spectrum of access to the company’s nationwide digital healthcare platform.

OptimizeRx Sales Momentum Continues with Two New Enterprise-level Engagements Added to its Digital Health Platform

ROCHESTER, Mich., June  29, 2020  (GLOBE NEWSWIRE) --  OptimizeRx Corp.  (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, payers, providers and patients, has engaged  UHY LLP  as its new auditor, effective Monday, June 22. There were no accounting disagreements or issues with the prior auditor.

OptimizeRx Engages UHY as New Independent Registered Public Accounting Firm

Slowly but surely, the company is cementing its position in the heart of the US healthcare sector, enabling participants to overcome some of the worst effects of its fragmentation.

OptimizeRx Is Entrenching Its Position In Digital Healthcare Communication

ROCHESTER, Mich., June  09, 2020  (GLOBE NEWSWIRE) --  OptimizeRx Corp.  (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, payers, providers, and patients, has finalized a new partnership that expands its digital communication platform by more than 300 health systems and 75,000 healthcare providers that utilize market-leading EHRs Epic and Cerner.

OptimizeRx Digital Health Platform Adds More than 300 Epic and Cerner Health Systems

ROCHESTER, Mich., May  07, 2020  (GLOBE NEWSWIRE) --  OptimizeRx Corp.  (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies and payers, announced its chief commercial officer, Steve Silvestro, has been  honored  with the  2020 PM360 ELITE 100  Award for his organizational leadership and positive impact on the healthcare industry.

News for OptimizeRx Corp Stock (OPRX)